Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-02-20
2007-02-20
Owens, Amelia A. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S134000, C546S135000
Reexamination Certificate
active
10684537
ABSTRACT:
This invention is directed towards substituted aminoquinuclidine compounds useful as delta-opioid receptor modulators, delta-opioid receptor agonists useful as analgesics and delta-opioid receptor antagonists useful as immunosuppressants, antiinflammatory agents, agents for the treatment of neurological and psychiatric conditions, medicaments for drug and alcohol abuse, agents for treating gastritis and diarrhea, cardiovascular agents and agents for the treatment of respiratory diseases.
REFERENCES:
patent: WO 99/33806 (1999-07-01), None
patent: WO 01/46191 (2001-06-01), None
Dondio, Development of novel pain relief agents acting through the selective activation of the delta-opioid receptor, II Farmaco 55 (2000) 178-180.
PCT International Search Report, dated Apr. 22, 2004, for PCT Int'l. Appln. No. PCT/US03/32221.
Boyd Robert E.
Reitz Allen B.
Harbour John
Ortho-McNeil Pharmaceutical , Inc.
Owens Amelia A.
LandOfFree
Substituted aminoquinuclidine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted aminoquinuclidine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted aminoquinuclidine compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3876326